Incannex Healthcare Faces Delisting Notice

TL;DR

INCANNEX HEALTHCARE INC. (NASDAQ: IXHL) got a delisting notice, might be moving exchanges.

AI Summary

Incannex Healthcare Inc. filed an 8-K on January 10, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule. The filing indicates a potential transfer of listing, with the earliest event reported on January 3, 2025. The company is incorporated in Delaware and its principal executive offices are located in Norwest, NSW, Australia.

Why It Matters

This filing signals potential issues with Incannex Healthcare's stock exchange listing, which could impact its liquidity and investor confidence.

Risk Assessment

Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's stock trading and overall market perception.

Key Players & Entities

• Incannex Healthcare Inc. (company) — Registrant
• January 3, 2025 (date) — Earliest event reported
• January 10, 2025 (date) — Filing date
• Delaware (jurisdiction) — State of incorporation
• Norwest, NSW, Australia (location) — Principal executive offices

FAQ

Key Financial Figures

• $0.0001 — nge on which registered Common Stock, $0.0001 par value per share IXHL The Nasdaq
• $50.0 million — Listed Securities ("MVLS") of at least $50.0 million. The Notice is only a notification of d

Filing Documents

• ea0227297-8k_incannex.htm (8-K) — 31KB
• 0001213900-25-002666.txt ( ) — 203KB
• ixhl-20250103.xsd (EX-101.SCH) — 3KB
• ixhl-20250103_lab.xml (EX-101.LAB) — 33KB
• ixhl-20250103_pre.xml (EX-101.PRE) — 22KB
• ea0227297-8k_incannex_htm.xml (XML) — 4KB

01. Notice of Delisting or Failure to Satisfy a Continued

Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On January 3, 2025, Incannex Healthcare Inc. (the "Company") received a written notice (the "Notice") from the Listing Qualifications Department (the "Staff") of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that the Company is not in compliance with Nasdaq Listing Rule 5450(b)(2)(A) (the "Listing Rule"), which requires the Company to maintain a minimum Market Value of Listed Securities ("MVLS") of at least $50.0 million. The Notice is only a notification of deficiency, not of imminent delisting, and has no current effect on the listing or trading of the Company's securities on the Nasdaq Global Market. The Notice states that the Company has 180 calendar days, or until July 2, 2025, to regain compliance with the Listing Rule. To regain compliance, the Company's MVLS must meet or exceed $50.0 million for a minimum of ten consecutive business days during the 180-day compliance period ending on July 2, 2025. Alternatively, the Company may submit an application and pay the related fee to transfer to The Nasdaq Capital Market (the "Capital Market") to take advantage of the Capital Market's listing requirements, provided that it then satisfies the applicable requirements for continued listing on the Capital Market. The Company intends to monitor its MVLS and consider its available options to regain compliance with the Listing Rule, including by way of transferring the listing of its common stock to the Capital Market. The Company does not anticipate that a transition of the listing of its common stock to the Capital Market would materially impact its prospects. Forward-Looking This Current Report on Form 8-K includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Certain of these forward-looking statements can be identified by t

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Incannex Healthcare Inc. Date: January 10, 2025 /s/ Joel Latham Name: Joel Latham Title: Chief Executive Officer and President 2

View Full Filing

View this 8-K filing on SEC EDGAR